Medicai has doubled its revenue over the past year and now manages more than 2 million medical imaging studies in Romania, representing up to 13% of the population. With over 8,500 registered physicians and 10 U.S. contracts already signed, the company is preparing for a new funding round and a major expansion into the U.S. market in 2025.
December 13, 2024
Medicai, the Romanian startup that built a medical data platform enabling healthcare providers to ingest, view, store, and quickly share medical imaging for better care coordination and faster research workflows, has doubled its revenue over the past year and is preparing for a significant expansion into the U.S. market in 2025.
“In the past year, we’ve seen growth of around 100% across our key indicators, including revenue. In Romania alone, we now manage approximately 2 million imaging studies—MRI, CT, X-ray and others. That means roughly 12–13% of the population has at least one imaging study stored with us. We also have 8,500 registered doctors—around 8% of all physicians in Romania—who have a Medicai account and have likely viewed or shared data through our platform,” said Mircea Popa, Medicai Co-Founder and CEO, in an interview on ZF IT Generation.
Mircea explains that Medicai’s core mission is to modernize the underlying infrastructure behind imaging workflows. “When you go for an MRI today, you still leave with a CD. The CD isn’t the real problem—it’s just a symptom. The issue lies in the outdated infrastructure underneath and the fact that most organizations have no other way to give you your data. We’re solving that infrastructure layer. We connect directly to the scanner, move the data into the cloud, and from there you can build workflows, apps, AI integrations—much more than traditional systems allow.”
After beginning its U.S. expansion roughly 18 months ago, Medicai has already signed 10 contracts in the American market—its top strategic priority moving forward.
“The United States is the most important market for a startup like ours. You want to prove you can succeed in a large market with a product that scales. We’ve already made strong initial progress, and in 2025 our goal is to build on the network we’ve established across several U.S. states,” Popa added.
Backed so far by GapMinder, ROCA X, Cleverage, and D Moonshots, Medicai plans to raise a new funding round in 2025. According to Popa, market conditions in 2024 forced many startups to focus on efficiency—but that may create better fundraising opportunities ahead.
“Overall, 2024 was a tough year for startups, which in some ways was a good thing. There were economic turbulences, valuations dropped significantly, and the cost of capital went up. As a startup, you’re forced to focus on efficiency, optimization, and on the things that truly matter. If what you’re building doesn’t make real sense, you might not survive. From that perspective, the year was useful—although challenging. Despite this, we managed to grow, to prepare the company for 2025, and to set up an even better launchpad for what comes next.”
If you're interested in publishing news about Medicai, send us a quick email:
Medicai replaces outdated CD-based workflows with an integrated cloud PACS and VNA, real-time collaboration tools, structured reporting, and AI-ready pathways. Trusted by thousands of clinicians, Medicai helps healthcare providers streamline imaging workflows, accelerate diagnosis, and scale across multiple locations and teams. Explore how Medicai can modernize your imaging operations.
Get the Medicai Mobile App
Investigations
Medical ImagingPET CT ScanMRI ScanCT ScanMammogramsAngiographyMR AngiographyUltrasoundDEXA Scans
